Abstract
ObjectiveMetabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern, with increasing mortality rates driven by the obesity pandemic. Weight loss has been shown to improve MASLD outcomes,...
Published Version
Join us for a 30 min session where you can share your feedback and ask us any queries you have